Site Location: Home > Client Services > Planning Services > Life Sciences
Market Forecasting services
Adequately evaluating new opportunities is critical for effective portfolio planning, capital allocation, partnering and investing. Accurate forecasts early in the product development life-cycle can make the difference between a yes/no decision for the project, and strongly influence alternative development pathways. Forecasts for pre-market technologies are also an imperative, when considering acquisitions, alliances or licensing opportunities.
How Expantium can help
Expantium provides a full array of Forecasting services including corporate planning, product planning and market forecasting services. Expantium's Forecasting services focus on understanding the market and competitive factors. Using a range of quantitative models alongside analytical methods and external market data, we can help clients to address and resolve issues relating to a range of financial and commercial circumstances. We help companies fund, develop, market, and launch products in an environment where raising capital is increasingly difficult and competition is fierce.
Custom epidemiological Forecasting
Expantium can provide tailor made epidemiological analysis of complex diseases using sophisticated analytical methods. We have significant experience in analysing and segmenting markets using rigorous techniques. This in-depth analysis considers many factors that affect the incidence/prevalence of a disease, including patient demographics and the impact of new treatments on changes in survival.
Patient Flow modelling
Expantium can provide detailed market modelling in areas where therapeutic history of patients and survival characteristics are key drivers, for example in areas such as oncology and HIV. Patient flow models can be used to assess future patient segments in shifting patient populations and changes in treatment regimens. Partitioning patients into first-line therapy and progressing them through multiple lines of therapy is modelled, applying assumptions for treatment allocation and rates of progression through the various therapies in order to predict market performance of the client’s treatment or technology.
Investment firms
Expantium works with a variety of financial firms, including equity investment funds and venture capital firms. Central to these firms’ investment evaluations is a robust forecast. Expantium offers specialised forecasting services for the decision-making needs of deal-oriented organisations, and can develop the necessary forecasting in the necessary detail.
<< Back to the Overview
To find out more about Expantium's work in this solution area or how we can support the growth objective of your organisation, please contact lifesciences@expantium.com, call us or complete the contact form.
